ALX-S001

Sylvester Comprehensive Cancer Center, University of Miami (Miami, FL) › ALX-S001

ALX-S001

A Phase 1 Study to Evaluate Intratumoral Doxorubicin Exposure Following Administration of Aldoxorubicin or Doxorubicin · Phase I
Sylvester Comprehensive Cancer Center, University of Miami (Miami, FL) · Dr. Nolan

screened

AEs

0

Serious

0

Dropout signal

–

Adverse events

0

No adverse events recorded. New events are triaged from the Safety tab.

Data queries

0

No data queries. Open queries would appear here for this patient.